Page 9 - Latest Updates on Q4 Results

Sundaram Finance Holdings Q4 results: Consolidated PAT at Rs 107.12 cr

Sundaram Finance Holdings Ltd reported a consolidated profit after tax of Rs 107.12 crore for the JanuaryMarch 2025 quarter, the company said on Friday. The Chennai-based firm had posted a profit after tax of Rs 269.32 crore in the corresponding quarter of the previous financial year. For the financial year ended March 31, 2025, consolidated profit after tax stood at Rs 412.08 crore, compared to Rs 533.14 crore in the year-ago period. In a statement, the company said the profit before tax in FY24 included a one-time gain of Rs 175.67 crore from the redemption of non-convertible redeemable preference shares of TVS Holdings Ltd. Excluding this, net profit for FY25 rose 15.28 per cent. Similarly, the profit before tax for the March 2024 quarter also included the same one-time receipt. Excluding it, net profit for the March 2025 quarter rose 14.38 per cent, the company said. Sundaram Finance Holdings primarily operates as a holding company with a portfolio of automotive businesses, ..

Smallcap packaging stock zooms 44% in 2 days on strong Q4 results

Shares of Cosmo First soared 20 per cent to ₹953.50 on the BSE in Friday's intra-day trade, extending its Thursday's rally, amid heavy volumes.

Emcure Pharma hits 10% upper circuit; gains 20% in three days; here's why

Emcure Pharma hit 10 per cent upper circuit after the pharma company's Q4 net profit stood at ₹197.2 crore as against ₹121 crore, up 62 per cent

ITC Hotels shares rally 11% in 3 days, hits new high on healthy outlook

ITC Hotels share price: A favorable demographic profile, steady domestic demand and rising consumption levels augur well for the hospitality industry in India

Why is Emkay Global constructive on Indian equities? Check why, top picks

With most of the events taking a back seat, the markets have been trading sideways, looking for a direction; Here's what Emkay recommend

Q4 results today: JSW Steel, Ashok Leyland, Glenmark Pharma on May 23

Q4 FY25 company results today: Reliance Infrastructure, Afcons and Narayana Hrudayalaya will be among 202 companies to post earnings reports for the January-March quarter

Stocks to Watch Today, May 23: ITC, Sun Pharma, IndusInd, Trent, TVS, Ola

Stocks to Watch Today, Friday, May 23: Grasim Industries, Honasa Consumer, Metro Brands, Gujarat State Petronet, Tata Steel, BEL, and Adani Ports are some of the top stocks to watch today

Sun Pharma results: Profit down 19% at Rs 2,149.8 cr, revenue up 8%

Sun Pharma's Q4 net profit fell 19% to Rs 2,149.8 crore due to input costs and US sales dip while FY25 profit rose 14% with strong domestic growth and specialty push

ITC Q4FY25 results: Adjusted profit rises 3% to Rs 5,155.27 crore

ITC reports Rs 5,155 crore adjusted PAT in Q4FY25, with one-time hotel demerger gain pushing reported profit to Rs 19,727 crore amid rising input costs and weak demand

IndiGo set for strong gains in FY26 on lower costs, capacity boost

While IndiGo posted a strong Q4 and has promising FY26 prospects due to falling fuel costs and capacity gains, Q1 may face pressure from geopolitical disruptions

Grasim Q4FY25 profit increases 9.2%; gains 10% share in paints market

Grasim Industries posts strong Q4 with 9.2% rise in profit and 17.3% revenue growth led by cement, paints and financial services while FY profit dips on higher costs

Airtel Payments Bank Q4 net profit jumps 138% to ₹26 crore, revenue up 35%

The payments bank posted revenue of ₹726 crore in Q4FY25, marking a 34.7 per cent increase compared to the same quarter last year

HFCL Q4 results: Net loss at ₹83 crore, revenue declines 39% to ₹800 crore

The Board of Directors has declared a 10 per cent dividend for the financial year 2024-25, translating to ₹0.10 per equity share with a face value of ₹1 each

Vishal Fabrics profit rises 13% in FY25 despite industry headwinds'

Denim fabric manufacturer Vishal Fabrics Ltd on Thursday said its profit rose by 13 per cent to Rs 28.84 crore in the financial year ended on March 31, 2025, despite global challenges and industry headwinds. The company had reported a profit of Rs 21.13 crore in the year-ago period. Total income of the Chiripal Group company rose by 5 per cent to Rs 1,521.43 crore in 2024-25 from Rs 1,451.29 crore in FY24. Despite global challenges and industry headwinds, our focus on efficiency, quality, and customer satisfaction has enabled us to achieve consistent growth, Dharmesh Dattani, CFO of Vishal Fabrics Limited, said. Vishal Fabrics continues to strengthen its presence in domestic and international markets through innovation in sustainable manufacturing and digital transformation, the company said in a statement.

ITC Q4 results: Net profit jumps multifold to ₹19,727 cr, dividend declared

The significant surge in profit is attributed to the exceptional gain from discontinued operations; ITC's board of directors recommended the dividend of ₹7.85 per share

Sun Pharma Q4 results: Net profit falls 19% to ₹2,153.9 cr, revenue up 8%

Sun Pharma posted a 19% drop in Q4 profit to ₹2,153.9 crore, while revenue rose 8.5%. India formulation sales grew 13.6%, and a ₹5.5 final dividend has been recommended

Emcure Q4 profit jumps 63%, domestic business drives 19.5% revenue rise

Emcure Pharma posted strong March quarter results with 63% rise in net profit and 19.5% growth in revenue, driven by robust domestic demand and global segment performance

Deepak Fertilisers Q4 results: PAT jumps 20.7% to ₹277 cr on higher income

Deepak Fertilisers and Petrochemicals Corporation Ltd (DFPCL) on Thursday posted a 20.74 per cent rise in consolidated net profit to Rs 277.66 crore for the fourth quarter of the 2024-25 fiscal on higher income. The company reported a net profit of Rs 229.96 crore a year ago, according to a regulatory filing. Its total income rose 26 per cent to Rs 2,716.99 crore during the January-March quarter of 2024-25, from Rs 2,158.56 crore in the year-ago period. The company's expenses remained higher at Rs 2,396.99 crore against Rs 1,862.20 crore. For the full 2024-25 fiscal, the company posted a two-fold jump in consolidated net profit to Rs 944.67 crore from Rs 467.56 crore in the previous year. The company said its strategic investments are on track. The overall progress in the TAN project in Gopalpur is at 75 per cent, and the same for the Nitric Acid project in Dahej is at 48 per cent. Bulk fertiliser manufactured sales volume in Q4 surged 68 per cent, driven by increased adoption o

Stock market crash highlights: Sensex sheds 645 pts, Nifty at 24,609; IT, FMCG, Oil & Gas top drag

Sensex Today | Stock Market Highlights on Thursday, May 22, 2025: In the broader basket, Nifty Midcap100 and Nifty Smallcap100 indices settled lower by 0.52 per cent and 0.26 per cent, respectively

Lincoln Pharma posts Rs 11.62 cr profit for Jan-Mar; revenue at Rs 161 cr

Lincoln Pharmaceuticals on Thursday reported a net profit of Rs 11.62 crore for the March quarter of 2024-25 and said it is building a portfolio in lifestyle and chronic segments, particularly in women's healthcare and dermatology. The Ahmedabad-based company in a statement said that it focuses on expanding its global footprint by registering new products for export and also building a portfolio in lifestyle and chronic segments. The pharma company had reported a net profit of Rs 18.8 crore in the year-ago period. Revenue from operations rose to Rs 161.30 crore in the last quarter of FY25 from Rs 149.51 crore in the year-ago period. "The company remain committed to net debt-free and continues to leverage strategic product launches in both domestic and international markets to strengthen our market presence," Lincoln Pharmaceuticals Managing Director Mahendra Patel said. For the full fiscal, the company reported a net profit of Rs 82.44 crore against Rs 93.36 crore in FY24. Total .